Gout Treatment: Immediate vs. Delayed Febuxostat

We are studying whether starting febuxostat right after a gout attack helps reduce the number of gout days compared to starting it six weeks later. This trial is for individuals experiencing acute gout attacks.

>2 years≤5 visitsConfirmation phase (III)No PlaceboStandard MedicinesOralOrthopedics and TraumatologyRheumatology

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What medicines are being studied?

Medicines that are officially approved for use in the European Union and considered safe by EMA. These medicines are already on the market and may be tested for new conditions or populations.

Febuxostat Viatris
Febuxostat Viatris is a medicine used to lower uric acid and help prevent gout attacks.

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Febuxostat
Febuxostat is a substance that lowers uric acid levels to help prevent gout attacks.

What similar medicines might you know?

Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.

Abuxar
Adenuric
Alphabux

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Centre Hospitalier Universitaire De Caen Normandie
Service de Rhumatologie
Caen, France
Centre Hospitalier Public Du Cotentin
Service Rhumatologie
Cherbourg, France
Groupe Hospitalier Du Havre
Service de Rhumatologie
Le Havre, France
Sponsor: Centre Hospitalier Universitaire Rouen
Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.